Moshe Mittelman

Report of an international working group to standardize response criteria for myelodysplastic syndromes.

Bruce D. Cheson, John M. Bennett, Hagop M. Kantarjian et al. · PubMed · 2000 · 665 citations

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

Luca Malcovati, Eva Hellström‐Lindberg, David Bowen et al. · Blood · 2013 · 663 citations · Full text

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag et al. · Blood · 2011 · 475 citations · Full text

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

Valeria Santini, António Almeida, Aristoteles Giagounidis et al. · Journal of Clinical Oncology · 2016 · 213 citations

Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models

Moshe Mittelman, Drorit Neumann, Alpha Peled et al. · Proceedings of the National Academy of Sciences · 2001 · 159 citations · Full text

Immunology, Immunotherapy, Tumor Biology +16